Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation

Acher, 1997, Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes, J. Med. Chem, 40, 3119, 10.1021/jm970207b Agostinho, 2010, Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease, Curr. Pharm. Des, 16, 2766, 10.2174/138161210793176572 Agostini, 2011, Cell death pathology: perspective for human diseases, Biochem. Biophys. Res. Commun, 414, 451, 10.1016/j.bbrc.2011.09.081 Allen, 1999, Beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: exacerbation by selective inhibition of group I metabotropic glutamate receptors, Neuropharmacology, 38, 1243, 10.1016/S0028-3908(99)00044-1 Allen, 2000, Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro, Cell Death Differ, 7, 470, 10.1038/sj.cdd.4400678 Beart, 2007, Hierarchical recruitment by AMPA but not staurosporine of pro-apoptotic mitochondrial signaling in cultured cortical neurons: evidence for caspase-dependent/independent cross-talk, J. Neurochem, 103, 2408, 10.1111/j.1471-4159.2007.04937.x Berent-Spillson, 2004, Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3, J. Neurochem, 89, 90, 10.1111/j.1471-4159.2003.02321.x Blaabjerg, 2003, Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents, Exp. Neurol, 183, 573, 10.1016/S0014-4886(03)00204-8 Boedtkjer, 2012, Intracellular pH in the resistance vasculature: regulation and functional implications, J. Vasc. Res, 49, 479, 10.1159/000341235 Borodezt, 1998, Decreased expression of the metabotropic glutamate receptor-4 gene is associated with neuronal apoptosis, J. Neurosci. Res, 53, 531, 10.1002/(SICI)1097-4547(19980901)53:5<531::AID-JNR3>3.0.CO;2-A Bredesen, 2006, Cell death in the nervous system, Nature, 443, 796, 10.1038/nature05293 Broadstock, 2012, Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata, Br. J. Pharmacol, 165, 1034, 10.1111/j.1476-5381.2011.01515.x Byrnes, 2009, Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders, Neurother, 6, 94, 10.1016/j.nurt.2008.10.038 Caraci, 2012, Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic?, Neurochem. Int, 61, 559, 10.1016/j.neuint.2012.01.017 Cavallucci, 2011, Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases, Curr. Pharm. Des, 17, 215, 10.2174/138161211795049705 Cheung, 2009, Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research, Neurotoxicology, 30, 127, 10.1016/j.neuro.2008.11.001 Conn, 2009, Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders, Nat. Rev. Drug Discov, 8, 41, 10.1038/nrd2760 Copani, 1995, Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide, Mol. Pharmacol, 47, 890 Culmsee, 2006, Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders, Curr. Alzheimer Res, 3, 269, 10.2174/156720506778249461 Dauer, 2003, Parkinson's disease: mechanisms and models, Neuron, 39, 889, 10.1016/S0896-6273(03)00568-3 Daugas, 2000, Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis, FASEB J., 14, 729, 10.1096/fasebj.14.5.729 Ding, 2000, Acidosis induces necrosis and apoptosis of cultured hippocampal neurons, Exp. Neurol, 162, 1, 10.1006/exnr.2000.7226 Diwakarla, 2009, GABAergic striatal neurons exhibit caspase-independent, mitochondrially mediated programmed cell death, J. Neurochem, 109, 198, 10.1111/j.1471-4159.2009.05937.x Domin, 2014, Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo, Neurotox. Res, 26, 99, 10.1007/s12640-013-9455-7 Durand, 2010, Metabotropic glutamate receptor 3 activation prevents nitric oxide-induced death in cultured rat astrocytes, J. Neurochem, 112, 420, 10.1111/j.1471-4159.2009.06469.x Duty, 2010, Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease, Br. J. Pharmacol, 161, 271, 10.1111/j.1476-5381.2010.00882.x Duvoisin, 2010, Acute pharmacological modulation of mGluR8 reduces measures of anxiety, Behav. Brain Res, 212, 168, 10.1016/j.bbr.2010.04.006 Faden, 2007, Neuroprotection: challenges and opportunities, Arch. Neurol, 64, 794, 10.1001/archneur.64.6.794 Flor, 2012, Orthosteric versus allosteric GPCR activation: the great challenge of group-III mGluRs, Biochem. Pharmacol, 84, 414, 10.1016/j.bcp.2012.04.013 Galluzzi, 2012, Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, Cell Death Differ, 19, 107, 10.1038/cdd.2011.96 Gómez, 2001, Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells, J. Neurosci. Res, 63, 421, 10.1002/1097-4547(20010301)63:5<421::AID-JNR1037>3.0.CO;2-4 Gottlieb, 1996, Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase, Proc. Natl. Acad. Sci. U.S.A., 92, 5965, 10.1073/pnas.92.13.5965 Grishchuk, 2011, Beclin 1-independent autophagy contributes to apoptosis in cortical neurons, Autophagy, 7, 1115, 10.4161/auto.7.10.16608 Guo, 2006, Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo, Invest. Ophthalmol. Vis. Sci, 47, 626, 10.1167/iovs.05-0754 Han, 2004, Enhanced group III mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala, Neuropharmacology, 46, 918, 10.1016/j.neuropharm.2004.01.006 Hellwig, 2011, The molecular machinery regulating apoptosis signal transduction and its implication in human physiology and pathophysiologies, Curr. Mol. Med, 11, 31, 10.2174/156652411794474400 Iacovelli, 2002, Native group-III metabotropic receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways, J. Neurochem, 82, 216, 10.1046/j.1471-4159.2002.00929.x Iacovelli, 2004, Regulation of mGlu4 metabotropic glutamate receptor signaling by type-2 G-protein coupled receptor kinase (GRK2), Mol. Pharmacol, 65, 1103, 10.1124/mol.65.5.1103 Jantas, 2008, The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells, Neurochem. Int, 52, 864, 10.1016/j.neuint.2007.10.003 Jantas, 2011, Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons, Neurotoxicology, 32, 845, 10.1016/j.neuro.2011.05.013 Jantas, 2014, The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: the effect blocked by inhibitors of MAPK/ERK1/2 and PI3-K/Akt pathways, Neurotox. Res, 25, 208, 10.1007/s12640-013-9430-3 Jantas, 2014, Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: the impact of cell differentiation state, Neuropharmacology, 83, 36, 10.1016/j.neuropharm.2014.03.019 Joza, 2009, AIF: not just an apoptosis-inducing factor, Ann. N. Y. Acad. Sci, 1171, 2, 10.1111/j.1749-6632.2009.04681.x Kabadi, 2014, Neuroprotective strategies for traumatic brain injury: improving clinical translation, Int. J. Mol. Sci, 15, 1216, 10.3390/ijms15011216 Kingston, 1999, Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795, Eur. J. Pharmacol, 377, 155, 10.1016/S0014-2999(99)00397-0 Lagadic-Gossmann, 2004, Alterations of intracellular pH homeostasis in apoptosis: origins and roles, Cell Death Differ, 11, 953, 10.1038/sj.cdd.4401466 Leskiewicz, 2008, Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons, J. Physiol. Pharmacol, 59, 457 Lin, 2014, Stimulating ERK/PI3K/NFκB signaling pathways upon activation of mGluR2/3 restores OGD-induced impairment in glutamate clearance in astrocytes, Eur. J. Neurosci, 39, 83, 10.1111/ejn.12383 Lin, 2001, The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells, J. Cereb. Blood Flow Metab, 21, 262, 10.1097/00004647-200103000-00010 Lopes, 2010, Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies, Brain Res, 1337, 85, 10.1016/j.brainres.2010.03.102 Luyt, 2006, Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis, J. Neurochem, 99, 641, 10.1111/j.1471-4159.2006.04103.x Maiese, 2000, Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection, J. Neurosci. Res, 62, 257, 10.1002/1097-4547(20001015)62:2<257::AID-JNR10>3.0.CO;2-H Maiese, 2008, Therapeutic promise and principles: metabotropic glutamate receptors, Oxid. Med. Cell. Longev, 1, 1, 10.4161/oxim.1.1.6842 Maj, 2003, (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection, Neuropharmacology, 45, 895, 10.1016/S0028-3908(03)00271-5 Majid, 2014, Neuroprotection in stroke: past, present, and future, ISRN Neurol, 2014, 515716, 10.1155/2014/515716 Matsuyama, 2000, Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis, Nat. Cell Biol, 2, 318, 10.1038/35014006 Mattson, 2006, Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders, Antioxid. Redox Signal, 8, 1997, 10.1089/ars.2006.8.1997 McQueen, 1991, Growth inhibition of hybridoma cells by ammonium ion: correlation with effects on intracellular pH, Bioprocess Eng, 49, 49 Meisenholder, 1996, Events in apoptosis. Acidification is downstream of protease activation and BCL-2 protection, J. Biol. Chem, 271, 16260, 10.1074/jbc.271.27.16260 Miloso, 2004, Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent, J. Neurosci. Res, 75, 241, 10.1002/jnr.10848 Moldrich, 2002, Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures, Neuropharmacology, 43, 189, 10.1016/S0028-3908(02)00111-9 Monn, 1997, J. Med. Chem, 40, 528, 10.1021/jm9606756 Movsesyan, 2004, MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor, J. Neurochem, 89, 1528, 10.1111/j.1471-4159.2004.02451.x Nagley, 2009, Multifaceted deaths orchestrated by mitochondria in neurones, Biochim. Biophys. Acta, 1802, 167, 10.1016/j.bbadis.2009.09.004 Navarro, 2009, Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease, J. Bioenerg. Biomembr, 41, 517, 10.1007/s10863-009-9250-6 Nickols, 2014, Development of allosteric modulators of GPCRs for treatment of CNS disorders, Neurobiol. Dis, 61, 55, 10.1016/j.nbd.2013.09.013 Nicoletti, 1999, Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection, Neuropharmacology, 38, 1477, 10.1016/S0028-3908(99)00102-1 Nicoletti, 2011, Metabotropic glutamate receptors: from the workbench to the bedside, Neuropharmacology, 60, 1017, 10.1016/j.neuropharm.2010.10.022 Niswender, 2008, Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4, Mol. Pharmacol, 74, 1345, 10.1124/mol.108.049551 Page, 2006, Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes, Neurochem. Int, 49, 413, 10.1016/j.neuint.2006.01.020 Park, 2012, Doxorubicin induces cytotoxicity through upregulation of pERK-dependent ATF3, PLoS ONE, 7, e44990, 10.1371/journal.pone.0044990 Pinteaux-Jones, 2008, Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors, J. Neurochem, 106, 442, 10.1111/j.1471-4159.2008.05426.x Presgraves, 2004, Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists, Neurotox. Res, 5, 579, 10.1007/BF03033178 Pshenichkin, 2008, Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation – possible role as a dependence receptor, Neuropharmacology, 55, 500, 10.1016/j.neuropharm.2008.06.039 Pucci, 2008, Insulin-like growth factor-1 inhibits STS-induced cell death and increases functional recovery of in vitro differentiated neurons, Cell Cycle, 7, 3869, 10.4161/cc.7.24.7261 Robichaud, 2011, Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics, ACS Chem. Neurosci, 2, 433, 10.1021/cn200043e Rothstein, 2009, Current hypotheses for the underlying biology of amyotrophic lateral sclerosis, Ann. Neurol, 65, S3, 10.1002/ana.21543 Sánchez-Rovira, 2012, Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study, Clin. Transl. Oncol, 14, 430, 10.1007/s12094-012-0820-4 Schapira, 2014, Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives, Lancet, 384, 545, 10.1016/S0140-6736(14)61010-2 Schoepp, 1997, LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors, Neuropharmacology, 36, 1, 10.1016/S0028-3908(96)00160-8 Silva, 2010, Secondary necrosis: the natural outcome of the complete apoptotic program, FEBS Lett, 584, 4491, 10.1016/j.febslet.2010.10.046 Silva, 2008, Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications, Apoptosis, 13, 463, 10.1007/s10495-008-0187-8 Subramaniam, 2010, ERK and cell death: ERK1/2 in neuronal death, FEBS J., 277, 22, 10.1111/j.1742-4658.2009.07367.x Sun, 2011, Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity, Eur. J. Pharmacol, 660, 283, 10.1016/j.ejphar.2011.03.046 Suzuki, 2007, In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allostericmetabotropic glutamate receptor 7 antagonists, J. Pharmacol. Exp. Ther, 323, 147, 10.1124/jpet.107.124701 Swerdlow, 2009, Mitochondrial medicine and the neurodegenerative mitochondriopathies, Pharmaceuthicals, 2, 150, 10.3390/ph2030150 Szydlowska, 2010, Prolonged activation of ERK triggers glutamate-induced apoptosis of astrocytes: neuroprotective effect of FK506, J. Neurochem, 113, 904, 10.1111/j.1471-4159.2010.06656.x Taylor, 2003, Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity, J. Neurosci, 23, 2150, 10.1523/JNEUROSCI.23-06-02150.2003 Tian, 2010, AMN082 promotes the proliferation and differentiation of neural progenitor cells with influence on phosphorylation of MAPK signaling pathways, Neurochem. Int, 57, 8, 10.1016/j.neuint.2010.04.004 Vernon, 2008, Additive neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson's model, Neuroreport, 19, 475, 10.1097/WNR.0b013e3282f602df Vincent, 2000, The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death, Exp. Neurol, 166, 65, 10.1006/exnr.2000.7487 Vincent, 1997, Metabotropic glutamate receptors prevent nitric oxide-induced programmed cell death, J. Neurosci. Res, 50, 549, 10.1002/(SICI)1097-4547(19971115)50:4<549::AID-JNR6>3.0.CO;2-E Vincent, 1999, Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH, Exp. Neurol, 155, 79, 10.1006/exnr.1998.6966 Vincent, 1999, Neuronal intracellular pH directly mediates nitric oxide-induced programmed cell death, J. Neurobiol, 40, 171, 10.1002/(SICI)1097-4695(199908)40:2<171::AID-NEU4>3.0.CO;2-F Wang, 2012, Neuroscience, 205, 167, 10.1016/j.neuroscience.2011.12.039 Wang, 2005, Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity, Neurosci. Res, 51, 129, 10.1016/j.neures.2004.10.001 Wenker, 2010, Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells, J. Cell. Biochem, 110, 151 Werner, 2007, Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance, Eur. J. Neurosci, 25, 3597, 10.1111/j.1460-9568.2007.05614.x Wu, 2004, Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells, J. Surg. Res, 122, 231, 10.1016/j.jss.2004.05.017 Yong-Kee, 2012, Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in Parkinson's disease, Neurotox. Res, 22, 355, 10.1007/s12640-012-9325-8 Yuste, 2005, The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA degradation during apoptosis, J. Biol. Chem, 280, 35670, 10.1074/jbc.M504015200 Zhang, 2013, The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells, Neuropharmacology, 52, 423, 10.1016/j.neuropharm.2006.08.020 Zhou, 2006, Activation of Group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake, J. Neurosci. Res, 84, 268, 10.1002/jnr.20897